These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22042780)

  • 1. US committee recommends HPV vaccine for boys.
    Roehr B
    BMJ; 2011 Oct; 343():d7068. PubMed ID: 22042780
    [No Abstract]   [Full Text] [Related]  

  • 2. HPV vaccine recommendations.
    Committee on Infectious Diseases
    Pediatrics; 2012 Mar; 129(3):602-5. PubMed ID: 22371460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDC's Advisory Committee recommends human papillomavirus virus vaccination.
    J Med Assoc Ga; 2006; 95(2):26. PubMed ID: 17042291
    [No Abstract]   [Full Text] [Related]  

  • 4. HPV vaccine is safe and effective and is now routinely recommended for preteen girls and boys.
    Michigan Department of Community Health
    Mich Med; 2012; 111(2):24-6. PubMed ID: 22594161
    [No Abstract]   [Full Text] [Related]  

  • 5. Organisations challenge basis for recommending HPV vaccine for boys.
    Lenzer J
    BMJ; 2011 Nov; 343():d7238. PubMed ID: 22065681
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for HPV immunization.
    Campos-Outcalt D
    J Fam Pract; 2009 Dec; 58(12):660-4. PubMed ID: 19961821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Questions remain about the human papillomavirus vaccine.
    Printz C
    Cancer; 2009 Feb; 115(4):699-701. PubMed ID: 19189370
    [No Abstract]   [Full Text] [Related]  

  • 9. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting to know human papillomavirus (HPV) and the HPV vaccines.
    Smith GD; Travis L
    J Am Osteopath Assoc; 2011 Mar; 111(3 Suppl 2):S29-34. PubMed ID: 21415377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human papillomavirus vaccine. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society. September 2008].
    Abarca V K; Valenzuela B MT; Vergara F R; Luchsinger F V; Muñoz M A; Jiménez de la Jara J; Ripoll M E; O'Ryan G M
    Rev Chilena Infectol; 2008 Dec; 25(6):428-34. PubMed ID: 19194605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).
    Smith JC
    Vaccine; 2010 Apr; 28 Suppl 1():A68-75. PubMed ID: 20413002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the presentation of news information about the HPV vaccine: a content analysis of a representative sample of U.S. newspaper articles.
    Quintero Johnson J; Sionean C; Scott AM
    Health Commun; 2011 Sep; 26(6):491-501. PubMed ID: 21469005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine: recommendations, issues and controversies.
    Fisher R; Darrow DH; Tranter M; Williams JV
    Curr Opin Pediatr; 2008 Aug; 20(4):441-5. PubMed ID: 18622201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine.
    Block SL; Brown DR; Chatterjee A; Gold MA; Sings HL; Meibohm A; Dana A; Haupt RM; Barr E; Tamms GM; Zhou H; Reisinger KS
    Pediatr Infect Dis J; 2010 Feb; 29(2):95-101. PubMed ID: 19952863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protecting our patients from HPV and HPV-related diseases: the role of vaccines.
    Mahoney MC
    J Fam Pract; 2006 Nov; Suppl():10-7. PubMed ID: 17366753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015.
    National Vaccine Advisory Committee
    Public Health Rep; 2016; 131(1):17-25. PubMed ID: 26843665
    [No Abstract]   [Full Text] [Related]  

  • 20. CancerScope: FDA Advisory Committee supports second HPV vaccine.
    Printz C
    Cancer; 2009 Nov; 115(22):5130. PubMed ID: 19890873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.